These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15582170)

  • 1. [Venous tromboembolic treatment in patients with cancer].
    Lévesque H; Belizna C; Michel P; Pfister C
    Rev Med Interne; 2004 Dec; 25(12):906-14. PubMed ID: 15582170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of venous thrombosis in the cancer patient.
    Levine MN; Lee AY
    Acta Haematol; 2001; 106(1-2):81-7. PubMed ID: 11549781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism and cancer: a two-way clinical association.
    Prandoni P; Piccioli A
    Front Biosci; 1997 Apr; 2():e12-20. PubMed ID: 9159235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer, coagulation, and anticoagulation.
    Letai A; Kuter DJ
    Oncologist; 1999; 4(6):443-9. PubMed ID: 10631688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Venous thromboembolism and cancer].
    Pavic M; Debourdeau P; Aletti M; Farge-Bancel D; Rousset H
    Rev Med Interne; 2006 Apr; 27(4):313-22. PubMed ID: 16414153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer and venous thromboembolism: an overview.
    Prandoni P; Piccioli A; Girolami A
    Haematologica; 1999 May; 84(5):437-45. PubMed ID: 10329923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients.
    Kovacs MJ; Levine MN; Keeney M; Mackinnon KM; Lee AY
    Thromb Haemost; 2005 Jun; 93(6):1185-8. PubMed ID: 15968406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
    Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
    N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer and venous thromboembolism.
    Prandoni P; Falanga A; Piccioli A
    Lancet Oncol; 2005 Jun; 6(6):401-10. PubMed ID: 15925818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in patients with cancer. Part II. Current treatment strategies.
    Viale PH; Schwartz RN
    Clin J Oncol Nurs; 2004 Oct; 8(5):465-9. PubMed ID: 15515280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ximelagatran in the treatment of venous thromboembolism.
    Schulman S
    Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():18-24. PubMed ID: 15812200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with recurrent venous thromboembolism in patients with malignant disease.
    Lin J; Proctor MC; Varma M; Greenfield LJ; Upchurch GR; Henke PK
    J Vasc Surg; 2003 May; 37(5):976-83. PubMed ID: 12756342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer and deep vein thrombosis].
    Malý J
    Vnitr Lek; 2010 Jan; 56(1):11-3. PubMed ID: 20184106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism.
    Motsch J; Walther A; Bock M; Böttiger BW
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):52-8. PubMed ID: 16547433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial treatment of venous thromboembolism.
    Becattini C; Agnelli G; Emmerich J; Bura A; Weitz JI
    Thromb Haemost; 2006 Sep; 96(3):242-50. PubMed ID: 16953263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
    Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
    JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of venous thromboembolic disorders: new challenges and opportunities.
    Prandoni P
    Haematologica; 2003 Jun; 88(6):610-3. PubMed ID: 12801835
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
    Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
    Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of venous thromboembolism in cancer patients.
    Lee AY; Levine MN
    Oncology (Williston Park); 2000 Mar; 14(3):409-17, 421; discussion 422, 425-6. PubMed ID: 10742967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.